Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial

Table 3

The mean score of SF-36, SF-36PH, and SF-36MH. Intention-to-treat population.

Scale	Group	Mean baseline (±s.d.)		Mean week 2 (±s.d.)	Mean CBTW2 (±s.d.)	Mean week 4 (±s.d.)	Mean C2WAT (±s.d.)
SF-36	Control ()	78.4 (7.1)	0.85	89.1 (3.3)	11.1 (6.4)	85.7 (5)	4.3 (3.8)
	Intervention ()	76.8 (8.1)		92.3 (2.7)	15.5 (6.3(	90.6 (3.7)	1.6 (2.2)
SF-36PH	Control ()	78.3 (5.8)	0.35	88.5 (4.1)	10.3 (7)	85.2 (7.4)	3.4 (5.1)
	Intervention ()	76.5 (6.6)		92 (3.3)	15.6 (6.7)	91 (3)	0.8 (2.2)
SF-36MH	Control ()	78.4 (9.2)	0.63	88.9 (5.4)	10.5 (7)	84.4 (8)	4.6 (3.9)
	Intervention ()	76.7 (10.3)		92 (4.2)	15.4 (6.8)	90.2 (5.2)	1.5 (2.8)

: value; SF-36: 36-Item Short-Form Health Survey; SF-36PH: 36-Item Short-Form Health Survey physical health; SF-36MH: 36-Item Short-Form Health Survey mental health; Mean CBTW2: mean change baseline to week 2; Mean C2WAT: mean change 2 week after treatment; Intervention vs. control; Intervention vs. control. Intervention (herbal medicine), control (omeprazole).